ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,788Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 53

$1.32M Total Retail Price of All Prescriptions

Rank: 3 out of 53

870 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 870 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

29% of this provider’s 870 patients filled at least one prescription for a schedule three drug, compared to an average of 24%.

Risky Drugs to Seniors

4% of this provider’s 13,887 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,382 705 S3 1 1
LISINOPRIL 782 440 2 2
SIMVASTATIN 749 418 3 3
FUROSEMIDE 672 472 4 4
OMEPRAZOLE 670 438 5 6
WARFARIN SODIUM 630 375 6 13
LEVOTHYROXINE SODIUM 505 306 7 5
BENZTROPINE MESYLATE 424 182 R 8 111
CITALOPRAM HBR 423 234 9 14
GABAPENTIN 393 197 10 10
METFORMIN HCL 387 268 11 8
AMLODIPINE BESYLATE 375 272 12 7
METOPROLOL TARTRATE 372 285 13 9
POTASSIUM CHLORIDE 356 218 14 12
ALENDRONATE SODIUM 299 217 15 67
RANITIDINE HCL 287 163 16 15
RISPERIDONE 282 191 17 66
TRAZODONE HCL 276 139 18 30
HYDROCHLOROTHIAZIDE 254 183 19 11
CLONIDINE HCL 236 160 20 33
LANTUS 209 120 21 32
NEXIUM 208 89 22 21
ZOLPIDEM TARTRATE 207 102 23 17
MELOXICAM 203 141 24 19
ALLOPURINOL 183 154 25 24
CARISOPRODOL 172 46 R 26 51
PANTOPRAZOLE SODIUM 165 107 27 40
DONEPEZIL HCL 162 122 28 37
GLYBURIDE 157 96 R 29 26
MIRTAZAPINE 150 118 30 46
PROMETHAZINE HCL 149 69 R 31 36
DIVALPROEX SODIUM 148 56 32 88
LOVASTATIN 146 104 33 22
NAMENDA 144 110 34 53
DIGOXIN 142 116 35 58
HALOPERIDOL 140 54 36 139
ATENOLOL 139 77 37 16
CLOPIDOGREL 138 107 38 27
CIPROFLOXACIN HCL 138 89 38 59
QUETIAPINE FUMARATE 138 61 38 65
PROAIR HFA 136 24 41 28
SEROQUEL 136 34 41 127
GLIPIZIDE 136 96 41 114
METOCLOPRAMIDE HCL 133 40 44 102
CARVEDILOL 133 102 44 20
HUMALOG 131 75 46 124
SERTRALINE HCL 128 90 47 31
CEPHALEXIN 128 77 47 93
DICLOFENAC SODIUM 128 37 47 63
TAMSULOSIN HCL 127 98 50 34
PLAVIX 124 93 51 43
CYCLOBENZAPRINE HCL 123 54 R 52 55
PHENYTOIN SODIUM EXTENDED 117 38 53 105
AZITHROMYCIN 114 40 54 41
SUBOXONE 113 11 55 84
LEXAPRO 112 59 56 189
CRESTOR 109 65 57 49
TRIAMTERENE-HCTZ 105 94 58 52
ISOSORBIDE MONONITRATE ER 103 85 59 60
METOPROLOL SUCCINATE 103 80 59 47
ADVAIR DISKUS 103 67 59 83
AMITRIPTYLINE HCL 98 34 R 62 57
ESCITALOPRAM OXALATE 97 75 63 129
LAMOTRIGINE 90 47 64 145
PREDNISONE 90 69 64 45
POLYETHYLENE GLYCOL 3350 90 75 64 80
FAMOTIDINE 88 56 67 54
SPIRIVA 87 53 68 50
CYMBALTA 87 60 68 62
BACLOFEN 86 24 70 79
VENLAFAXINE HCL ER 83 34 71 167
SPIRONOLACTONE 82 63 72 100
PEG 3350-ELECTROLYTE 82 23 72 201
GEMFIBROZIL 82 48 72 96
RISPERDAL CONSTA 81 45 75 203
ACTOS 80 73 76 113
RAMIPRIL 78 76 77 107
PREMARIN 78 53 R 77 98
CARBAMAZEPINE 77 43 79 148
IBUPROFEN 76 25 80 68
CLOZAPINE 76 12 80 206
MORPHINE SULFATE ER 73 0 S2 82 38
SINGULAIR 73 50 82 118
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 45 82 75
TERAZOSIN HCL 72 65 85 139
DIVALPROEX SODIUM ER 69 24 86 212
BUSPIRONE HCL 68 55 87 126
ATORVASTATIN CALCIUM 68 28 87 35
VERAPAMIL ER 67 33 89 85
GLIMEPIRIDE 66 47 90 69
OXYBUTYNIN CHLORIDE 65 59 91 133
FLUCONAZOLE 64 23 92 151
LEVETIRACETAM 63 14 93 121
FLUOXETINE HCL 63 52 93 44
METFORMIN HCL ER 62 28 95 82
TRAMADOL HCL 62 53 95 18
CYPROHEPTADINE HCL 62 44 R 95 187
DILTIAZEM 24HR CD 62 50 95 97
METHOCARBAMOL 61 0 R 99 101
SEROQUEL XR 60 19 100 171
INSULIN SYRINGE 59 32 101 76
EXELON 59 50 101 142
DIOVAN 58 32 103 77
ROPINIROLE HCL 57 31 104 70
SUCRALFATE 56 32 105 154
LOSARTAN POTASSIUM 55 55 106 39
LANSOPRAZOLE 54 28 107 184
DILTIAZEM ER 54 48 107 116
DEXILANT 53 45 109 120
VENTOLIN HFA 53 23 109 72
PAROXETINE HCL 53 26 109 81
LATUDA 52 15 112 235
DICYCLOMINE HCL 52 0 112 173
ENALAPRIL MALEATE 51 26 114 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.